Literature DB >> 14961198

Deterioration of hepatic functional reserve in patients with hepatocellular carcinoma after resection: incidence, risk factors, and association with intrahepatic tumor recurrence.

Teh-Ia Huo1, Wing-Yu Lui, Jaw-Ching Wu, Yi-Hsiang Huang, Kuang-Liang King, Che-Chuan Loong, Pui-Ching Lee, Full-Young Chang, Shou-Dong Lee.   

Abstract

Hepatocellular carcinoma (HCC) is frequently associated with liver cirrhosis. Patients with HCCs undergoing surgical resection may have declining hepatic functional reserve over time. However, the incidence and risk factors of hepatic decompensation, and its relation to postoperative tumor recurrence are unknown. This study investigated 241 HCC patients (208 male; age 61 +/- 13 years) undergoing resection with a long-term follow-up. The Child-Pugh scoring system was used to evaluate the postoperative deterioration of liver reserve, defined as a sustained increment in the Child-Pugh score by 2 or more. The 1-, 3-, and 5-year cumulative probabilities of postoperative decompensation were 14%, 32%, and 56%, respectively, during a follow-up period of 27 +/- 18 months (range 3-75 months). The average increment in Child-Pugh score was 1.4 +/- 1.1 in 2.3 +/- 1.5 years, or 0.6 point per year. Altogether, 74 (31%) patients developed postoperative hepatic decompensation during the follow-up period, 43 (58%) of whom had decompensation within 2 years of resection. Large (> 3 cm) tumor size was the only independent predictor associated with hepatic decompensation (relative risk 1.7, 95% confidence interval 1.1-2.8, p = 0.041) and was a significant risk factor for intrahepatic tumor recurrence ( p = 0.018). Patients with tumor recurrence more frequently (40% of 109 patients vs. 23% of 132 patients, p = 0.005) and more rapidly (0.8 vs. 0.4 point per year) developed hepatic decompensation than those without recurrence. In conclusion, large HCCs are closely associated with hepatic decompensation in patients after resection. Tumor recurrence may predispose to the development of hepatic decompensation in these patients.

Entities:  

Mesh:

Year:  2004        PMID: 14961198     DOI: 10.1007/s00268-003-7182-6

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  31 in total

1.  Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies.

Authors:  H A EDMONDSON; P E STEINER
Journal:  Cancer       Date:  1954-05       Impact factor: 6.860

2.  Surgical resection for recurrent hepatocellular carcinoma: prognosis and analysis of risk factors.

Authors:  R H Hu; P H Lee; S C Yu; H C Dai; J C Sheu; M Y Lai; H C Hsu; D S Chen
Journal:  Surgery       Date:  1996-07       Impact factor: 3.982

Review 3.  Screening for hepatocellular carcinoma.

Authors:  G H Haydon; P C Hayes
Journal:  Eur J Gastroenterol Hepatol       Date:  1996-09       Impact factor: 2.566

4.  Hepatitis C virus genotypes and viremia and hepatocellular carcinoma in the United States.

Authors:  A E Reid; M J Koziel; I Aiza; L Jeffers; R Reddy; E Schiff; J Y Lau; J L Dienstag; T J Liang
Journal:  Am J Gastroenterol       Date:  1999-06       Impact factor: 10.864

5.  Prognostic factors and survival after hepatic resection for hepatocellular carcinoma without cirrhosis.

Authors:  N Nagasue; T Ono; A Yamanoi; H Kohno; O N El-Assal; H Taniura; M Uchida
Journal:  Br J Surg       Date:  2001-04       Impact factor: 6.939

6.  Risk factors for recurrence after resection of hepatitis C virus-related hepatocellular carcinoma.

Authors:  S Kubo; K Hirohashi; H Tanaka; T Tsukamoto; T Shuto; T Ikebe; T Yamamoto; K Wakasa; S Nishiguchi; T Kuroki; H Kinoshita
Journal:  World J Surg       Date:  2000-12       Impact factor: 3.352

7.  Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma.

Authors:  T J Tsai; G Y Chau; W Y Lui; S H Tsay; K L King; C C Loong; C Y Hsia; C W Wu
Journal:  Surgery       Date:  2000-06       Impact factor: 3.982

Review 8.  Repeated liver resection for recurrent liver cancer.

Authors:  N Neeleman; R Andersson
Journal:  Br J Surg       Date:  1996-07       Impact factor: 6.939

9.  Comparison of percutaneous acetic acid injection and percutaneous ethanol injection for hepatocellular carcinoma in cirrhotic patients: a prospective study.

Authors:  T I Huo; Y H Huang; J C Wu; P C Lee; F Y Chang; S D Lee
Journal:  Scand J Gastroenterol       Date:  2003-07       Impact factor: 2.423

10.  Hepatic segmentectomy for curative resection of primary hepatocellular carcinoma.

Authors:  W Y Lui; G Y Chau; C C Loong; S H Tsay; J C Wu; K L King; J H Chiu; C R Lai; F K P'eng
Journal:  Arch Surg       Date:  1995-10
View more
  7 in total

1.  Clinical analysis of the risk factors for recurrence of HCC and its relationship with HBV.

Authors:  Di-Peng Ou; Lian-Yue Yang; Geng-Wen Huang; Yi-Ming Tao; Xiang Ding; Zhi-Gang Chang
Journal:  World J Gastroenterol       Date:  2005-04-14       Impact factor: 5.742

Review 2.  Defining Post Hepatectomy Liver Insufficiency: Where do We stand?

Authors:  Kelly Lafaro; Stefan Buettner; Hadia Maqsood; Doris Wagner; Fabio Bagante; Gaya Spolverato; Li Xu; Ihab Kamel; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2015-06-11       Impact factor: 3.452

3.  Ascites in patients with hepatocellular carcinoma: prevalence, associated factors, prognostic impact, and staging strategy.

Authors:  Chia-Yang Hsu; Yun-Hsuan Lee; Yi-Hsiang Huang; Cheng-Yuan Hsia; Chien-Wei Su; Han-Chieh Lin; Rheun-Chuan Lee; Yi-You Chiou; Fa-Yauh Lee; Teh-Ia Huo; Shou-Dong Lee
Journal:  Hepatol Int       Date:  2012-01-08       Impact factor: 6.047

4.  Lipiodolized transarterial chemoembolization in hepatocellular carcinoma patients after curative resection.

Authors:  Xiaohong Chen; Boheng Zhang; Xin Yin; Zhenggang Ren; Shuangjian Qiu; Jian Zhou
Journal:  J Cancer Res Clin Oncol       Date:  2013-02-03       Impact factor: 4.553

Review 5.  Update on Liver Failure Following Hepatic Resection: Strategies for Prediction and Avoidance of Post-operative Liver Insufficiency.

Authors:  Amir A Rahnemai-Azar; Jordan M Cloyd; Sharon M Weber; Mary Dillhoff; Carl Schmidt; Emily R Winslow; Timothy M Pawlik
Journal:  J Clin Transl Hepatol       Date:  2017-11-30

6.  A prognostic nomogram based on LASSO Cox regression in patients with alpha-fetoprotein-negative hepatocellular carcinoma following non-surgical therapy.

Authors:  Dongdong Zhou; Xiaoli Liu; Xinhui Wang; Fengna Yan; Peng Wang; Huiwen Yan; Yuyong Jiang; Zhiyun Yang
Journal:  BMC Cancer       Date:  2021-03-08       Impact factor: 4.430

7.  Outcomes of curative liver resection for hepatocellular carcinoma in patients with cirrhosis.

Authors:  Omar Elshaarawy; Aya Aman; Hazem Mohamed Zakaria; Talaat Zakareya; Asmaa Gomaa; Esam Elshimi; Eman Abdelsameea
Journal:  World J Gastrointest Oncol       Date:  2021-05-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.